Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy

被引:11
作者
Pauschinger, M [1 ]
Chandrasekharan, K [1 ]
Li, J [1 ]
Schwimmbeck, PL [1 ]
Noutsias, M [1 ]
Schultheiss, HP [1 ]
机构
[1] Free Univ Berlin, Klinikum Benjamin Franklin, Klin Innere Med 2, D-12200 Berlin, Germany
关键词
myocarditis; cytokines matrix; metalloproteinases; extracellular matrix;
D O I
10.1007/s00059-002-2413-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The mechanisms underlying myocardial remodeling during heart failure have historically been attributed as the consequence of intrinsic changes in cardiac myocytes. Nevertheless, over the last several years, it has become increasingly evident that disruption of extracellular matrix (ECM) homeostasis is also a deciding factor for the progression of myocardial failure. Pathogenetic Mechanisms: Collagens, the chief components of extracellular matrix, are a tightly regulated family of proteins that determine the structural and functional integrity of heart. Synthesis of collagens is regulated at the cellular level while deposition of these proteins depend on a balance between matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinase (TIMPs). Infiltrating inflammatory cells are major producers of MMPs though myocardial cells are also found to synthesize these proteolytic enzymes. However, immune-mediated regulation of myocardial collagen synthesis and deposition during myocardial inflammation remains poorly understood. It seems likely that a paracrine/autorine effect of a repertoire of cytokines on inflammatory cells and myocardial cells may lead to an imbalance in myocardial MMP/TIMP ratio resulting, eventually, in altered myocardial extracellular matrix architecture and contribute significantly to the development of left ventricular remodeling and dysfunction. Conclusion: Attempts to delineate the cross-talk between immune cells, myocardial cells and extracellular matrix are important as chronic myocardial inflammation is documented in about 50% of patients with dilated cardiomyopathy.
引用
收藏
页码:677 / 682
页数:6
相关论文
共 47 条
[1]   Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro - TIMP-3 promotes apoptosis [J].
Baker, AH ;
Zaltsman, AB ;
George, SJ ;
Newby, AC .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) :1478-1487
[2]   Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload [J].
Chancey, AL ;
Brower, GL ;
Peterson, JT ;
Janicki, JS .
CIRCULATION, 2002, 105 (16) :1983-1988
[3]  
CZAJA MJ, 1987, J BIOL CHEM, V262, P13348
[4]  
Edwards DR, 1996, INT J OBESITY, V20, pS9
[5]  
EGHBALI M, 1992, BASIC RES CARDIOL, V87, P183
[6]   DIFFERENTIAL-EFFECTS OF TRANSFORMING GROWTH FACTOR-BETA-1 AND PHORBOL-MYRISTATE ACETATE ON CARDIAC FIBROBLASTS - REGULATION OF FIBRILLAR COLLAGEN MESSENGER-RNAS AND EXPRESSION OF EARLY TRANSCRIPTION FACTORS [J].
EGHBALI, M ;
TOMEK, R ;
SUKHATME, VP ;
WOODS, C ;
BHAMBI, B .
CIRCULATION RESEARCH, 1991, 69 (02) :483-490
[7]   HUMAN 72-KILODALTON TYPE-IV COLLAGENASE FORMS A COMPLEX WITH A TISSUE INHIBITOR OF METALLOPROTEASES DESIGNATED TIMP-2 [J].
GOLDBERG, GI ;
MARMER, BL ;
GRANT, GA ;
EISEN, AZ ;
WILHELM, S ;
HE, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8207-8211
[8]   Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 [J].
GomisRuth, FX ;
Maskos, K ;
Betz, M ;
Bergner, A ;
Huber, R ;
Suzuki, K ;
Yoshida, N ;
Nagase, H ;
Brew, K ;
Bourenkov, GP ;
Bartunik, H ;
Bode, W .
NATURE, 1997, 389 (6646) :77-81
[9]   Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4 [J].
Greene, J ;
Wang, MS ;
Liu, YLE ;
Raymond, LA ;
Rosen, C ;
Shi, YNE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30375-30380
[10]  
GunjaSmith Z, 1996, AM J PATHOL, V148, P1639